FOXO Technologies Announces Filing of Annual Report
FOXO Technologies Inc. (NYSE American: FOXO) proudly announces that it has submitted its Annual Report on Form 10-K. This crucial document was officially filed on April 15. The company is dedicated to transparently communicating its financial standing and operational progress to its stakeholders.
Key Highlights from the Annual Report
In line with the NYSE American Company Guidelines, FOXO has disclosed the audited financial statements for the fiscal year that concluded on December 31. Notably, the Annual Report includes an audit opinion indicating concerns regarding the company's ongoing viability. However, it’s important to note that this situation does not alter FOXO's financial statements or overall report for the year.
CEO's Perspective on 2024
CEO Seamus Lagan shared insights about the company’s journey through the past year. “We are pleased to file our 2024 Annual Report, which reflects a year of significant transition for FOXO. During 2024, we overcame numerous challenges successfully, including the acquisitions of Myrtle Recovery Centers, Inc. and Rennova Community Health, Inc.,” he stated. These acquisitions are part of FOXO's strategic vision aimed at positioning the company for further growth in 2025.
About FOXO Technologies Inc.
FOXO operates via several subsidiaries, each contributing to its overarching mission of enhancing human health and lifespan.
Rennova Community Health, Inc.
One of its notable subsidiaries, Rennova Community Health, operates Scott County Community Hospital. This facility, designated as a critical access hospital, serves the East Tennessee region, providing essential healthcare services to the local community.
Myrtle Recovery Centers, Inc.
Another significant part of FOXO’s portfolio is Myrtle Recovery Centers. This subsidiary operates a behavioral health facility offering 30 inpatient beds. Myrtle Recovery focuses on detoxification services and ongoing treatment programs, fulfilling an essential role in addiction recovery.
FOXO Labs, Inc.
Additionally, FOXO Labs is dedicated to pioneering advancements in biotechnology. The company strives to improve health outcomes through innovative technologies and product solutions designed for various industries.
Future Outlook for FOXO Technologies
Looking ahead, FOXO Technologies is enthusiastic about its growth trajectory. With strategic acquisitions complete, the focus will now shift toward strengthening existing operations and exploring new opportunities. The current landscape presents a wealth of potential through partnerships and further expansions.
Conclusion
FOXO Technologies Inc. is poised to leverage its recent acquisitions to enhance its service offerings and drive business growth. The 2024 fiscal year stands as a testament to its resilience and commitment to advancing health technology solutions. For ongoing updates and more detailed information about FOXO's endeavors, accessible resources are available on its website.
Frequently Asked Questions
What is Form 10-K?
Form 10-K is an annual report required by the SEC that provides a comprehensive overview of a company's business, financial condition, and audited financial statements.
What does FOXO's Annual Report indicate?
The report includes financial data and disclosures, including an audit opinion about the company's ability to continue operations.
Who are FOXO's recent acquisition targets?
FOXO has recently acquired Myrtle Recovery Centers and Rennova Community Health to expand its healthcare services.
What role does FOXO Labs play in the organization?
FOXO Labs focuses on biotechnology advancements aimed at enhancing health and lifespan, driving innovation within the company's portfolio.
How can I contact FOXO Technologies for more information?
For inquiries, you can reach out to Sebastien Sainsbury via email at ssainsbury@foxotechnologies.com or by phone at (561) 485-0151.
